| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 3 | -9.31M | 100% | $30.38 | -$283M |
| Net | -3 | -9.31M | -100% | -$283M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Valor IV Pharma Holdings, LLC | 10%+ Owner | $201M | -$139M | -41% | Nov 1, 2024 |
| Marshman Fund Trust II | 10%+ Owner | $183M | -$139M | -43.2% | Nov 1, 2024 |
| Andreas Wicki | Director | $71.7M | Dec 12, 2022 | ||
| Sandip Kapadia | Chief Financial Officer | $4.72M | Sep 30, 2024 | ||
| Jeffrey Dierks | Chief Commercial Officer | $3.6M | -$3.99M | -52.6% | Oct 29, 2024 |
| Kumar Budur | Chief Medical Officer | $2.55M | May 1, 2024 | ||
| Jeffrey M. Dayno | PRESIDENT, CEO, Director | $1.4M | Jan 24, 2024 | ||
| Andrew Serafin | Chief Strategy Officer | $334K | Jan 24, 2024 | ||
| Juan A. Sabater | Director | May 29, 2024 | |||
| Jack Nielsen | Director | May 29, 2024 | |||
| Linda M. Szyper | Director | May 29, 2024 | |||
| Peter Anastasiou | Director | May 29, 2024 | |||
| Gary Sender | Director | May 29, 2024 | |||
| Eric Motley | Director | May 20, 2021 | |||
| R. Mark Graf | Director | May 29, 2024 | |||
| Jeffrey S. Aronin | Director | Mar 24, 2022 | |||
| John C. Jacobs | PRESIDENT, CEO, Director | Aug 15, 2022 | |||
| Antonio J. Gracias | Director | May 29, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|